TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9505161

Group type: EXPERIMENTAL
Intervention: Vitamin E supplementation (280 mg daily for 10 weeks)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo supplementation
Number of subjects: 60
Study: 7785553

Group type: EXPERIMENTAL
Intervention: Ofloxacin for 7 days after ESWL (Group A, n = 66)
Number of subjects: 161

Group type: COMPARATOR
Intervention: No antimicrobial (Group B, n = 67)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Flomoxef intravenously for 2 or 3 days and ofloxacin for 4 or 5 days thereafter (Group C, n = 10)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Flomoxef only for 2 or 3 days and no drugs later (Group D, n = 10)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Ofloxacin for 7 days (Group E, n = 8)
Number of subjects: 161
Study: 2186055

Group type: EXPERIMENTAL
Intervention: SMS 201-995
Number of subjects: 26

Group type: COMPARATOR
Intervention: Bromocriptine
Number of subjects: 26
Study: 372839

Group type: EXPERIMENTAL
Intervention: Lithium treatment (therapeutic serum levels of 0.7-1.1 mmol/L)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31980913

Group type: EXPERIMENTAL
Intervention: DC vaccination with cisplatin
Number of subjects: 54

Group type: COMPARATOR
Intervention: DC vaccination without cisplatin
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Combination therapy (DC vaccination + cisplatin)
Number of subjects: 54
Study: 31151333

Group type: EXPERIMENTAL
Intervention: Complex Decongestive Therapy (CDT) - 10 sessions over 2 weeks
Number of subjects: 38

Group type: COMPARATOR
Intervention: Stellate Ganglion Block (SGB) - 3 consecutive blocks every 2 weeks
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Quality of Life measures (EQ-5D and EQ VAS)
Number of subjects: 38
Study: 27756513

Group type: EXPERIMENTAL
Intervention: Automated CPR using the Lifeline ARM
Number of subjects: 78

Group type: COMPARATOR
Intervention: Manual CPR
Number of subjects: 78
Study: 25888111

Group type: EXPERIMENTAL
Intervention: Midline incision
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Paramedian incision
Number of subjects: 20

Group type: COMPARATOR
Intervention: Both incision types
Number of subjects: 20
Study: 24392996

Group type: EXPERIMENTAL
Intervention: Injection-site warming device (InsuPad)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Control group (no warming device)
Number of subjects: 145
Study: 22560125

Group type: EXPERIMENTAL
Intervention: Polypodium leucotomos extract
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study: 19362013

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sufentanil
Number of subjects: 30
Study: 17985398

Group type: EXPERIMENTAL
Intervention: Experimental intervention (84.6% of abstracts explicitly described this)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Comparator intervention (37.1% of abstracts explicitly described this)
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Intention to treat analysis
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Effect size reporting
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Blinding information
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Eligibility criteria
Number of subjects: 143
Study: 15650515

Group type: EXPERIMENTAL
Intervention: Latanoprost
Number of subjects: 82

Group type: COMPARATOR
Intervention: Unoprostone
Number of subjects: 82
Study: 12126907

Group type: EXPERIMENTAL
Intervention: RV3 vaccine (6.5 x 10(5) fcfu)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9818858

Group type: EXPERIMENTAL
Intervention: Sulfasalazine
Number of subjects: 199

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 199
Study: 7895551

Group type: EXPERIMENTAL
Intervention: 30 mg lansoprazole once daily
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: 60 mg lansoprazole once daily
Number of subjects: 54
Study: 2702840

Group type: EXPERIMENTAL
Intervention: Trendelenburg position (TREND) at 20 degrees
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Passive leg raising (PLR) at 60 degrees
Number of subjects: 18
Study: 284719

Group type: EXPERIMENTAL
Intervention: Propylthiouracil (both intravenous and oral administration)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Graphical method for calculating kinetics parameters
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Computer program for calculating kinetics parameters
Number of subjects: 9

Group type: COMPARATOR
Intervention: Comparison between age groups
Number of subjects: 9
Study: 31134274

Group type: EXPERIMENTAL
Intervention: Rapeseed expeller cake (REC) at 7% and 14% from DY6, DY5, MB1, and XH3 varieties
Number of subjects: 1080

Group type: EXPERIMENTAL
Intervention: Rapeseed expeller cake (REC)
Number of subjects: 1080

Group type: EXPERIMENTAL
Intervention: XH3 REC
Number of subjects: 1080

Group type: EXPERIMENTAL
Intervention: DY6 REC
Number of subjects: 1080

Group type: EXPERIMENTAL
Intervention: XH3, MB1, and DY5 REC
Number of subjects: 1080

Group type: EXPERIMENTAL
Intervention: XH3 and DY5 REC
Number of subjects: 1080
Study: 28624750

Group type: EXPERIMENTAL
Intervention: Air filtration intervention
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 200
Study: 25503599

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) coping skills training
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) skills use
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (waitlist)
Number of subjects: 46
Study: 23240643

Group type: EXPERIMENTAL
Intervention: Manidipine 20 mg
Number of subjects: 104

Group type: COMPARATOR
Intervention: Amlodipine 10 mg
Number of subjects: 104
Study: 21325105

Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation (500 mg vitamin C and 400 IU vitamin E daily)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 19893971

Group type: EXPERIMENTAL
Intervention: Gluma Desensitizer (GD)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Seal& (SP)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Oxa-gel (OG)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Fluoride (F)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Low intensity laser-LILT (660 nm/3.8 J/cm(2)/15 mW)
Number of subjects: 101
Study: 16899098

Group type: EXPERIMENTAL
Intervention: Tooth brushing and inter‐dental flossing
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Tooth brushing and tongue scraping
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Tooth brushing, inter‐dental flossing and tongue scraping
Number of subjects: 19

Group type: COMPARATOR
Intervention: Tooth brushing
Number of subjects: 19
Study: 16946177

Group type: EXPERIMENTAL
Intervention: Tranylcypromine
Number of subjects: 109

Group type: COMPARATOR
Intervention: Extended-release venlafaxine plus mirtazapine
Number of subjects: 109
Study: 14570856

Group type: EXPERIMENTAL
Intervention: 0.5 mg of the MR agonist fludrocortisone
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 11789203

Group type: EXPERIMENTAL
Intervention: Xiongshao capsule (XSC)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Routine treatment plus XSC
Number of subjects: 65

Group type: COMPARATOR
Intervention: Routine treatment (Control)
Number of subjects: 65
Study: 8887014

Group type: EXPERIMENTAL
Intervention: benfluorex (150 mg x 3 daily)
Number of subjects: 32

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 32
Study: 2005918

Group type: EXPERIMENTAL
Intervention: TGLVP (5.0, 7.5, or 10.0 micrograms/kg of body weight)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: TGLVP
Number of subjects: 7
Study: 6419593

Group type: EXPERIMENTAL
Intervention: Auranofin, 3 mg twice daily
Number of subjects: 340

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 340
Study: 31609464

Group type: EXPERIMENTAL
Intervention: Metoclopramide
Number of subjects: 111

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study: 29653569

Group type: EXPERIMENTAL
Intervention: Needle acupuncture
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Verum laser acupuncture
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo laser acupuncture
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Needle acupuncture and laser acupuncture
Number of subjects: 180
Study: 28158576

Group type: EXPERIMENTAL
Intervention: Telenephrology (web-based consultation)
Number of subjects: 3004

Group type: COMPARATOR
Intervention: Enhanced usual care (control)
Number of subjects: 3004
Study: 25827597

Group type: EXPERIMENTAL
Intervention: Intravenous acetaminophen
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Intramuscular injection diclofenac sodium (75 mg)
Number of subjects: 121
Study: 23253958

Group type: EXPERIMENTAL
Intervention: Saw palmetto extract (320 mg for the first 24 weeks, 640 mg for the next 24 weeks, and 960 mg for the last 24 weeks)
Number of subjects: 369

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 369
Study: 21982622

Group type: EXPERIMENTAL
Intervention: Mepitel(®)
Number of subjects: 15

Group type: COMPARATOR
Intervention: SurfaSoft(®)
Number of subjects: 15
Study: 18182539

Group type: EXPERIMENTAL
Intervention: Journey of Hope course (intervention group)
Number of subjects: 462
Study: 16675962

Group type: EXPERIMENTAL
Intervention: Thiazolidinediones
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fibrates
Number of subjects: 0

Group type: COMPARATOR
Intervention: Isotretinoin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PPAR ligands (GW7647, GW0742, GW2433, rosiglitazone, GW4148)
Number of subjects: 0
Study: 14985300

Group type: EXPERIMENTAL
Intervention: 0.005% latanoprost administered as 1 drop
Number of subjects: 24
Study: 10902624

Group type: EXPERIMENTAL
Intervention: 23-valent pneumococcal polysaccharide vaccine
Number of subjects: 1392

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1392
Study: 9302882

Group type: EXPERIMENTAL
Intervention: Positive pressure breathing (PPB) after rapid decompression to 72,000 feet
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Positive pressure breathing (PPB) at ground level
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Low oxygen mixtures at ground level
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: PPB and low pressure at high altitude
Number of subjects: 6
Study: 8342828

Group type: EXPERIMENTAL
Intervention: 0.2 mg ITMS
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 0.4 mg ITMS
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 0.6 mg ITMS
Number of subjects: 20
Study: 3790968

Group type: EXPERIMENTAL
Intervention: Continuous infusion of metoclopramide (7 mg/kg)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Intermittent infusion of metoclopramide (7 mg/kg)
Number of subjects: 33
Study: 29595585

Group type: EXPERIMENTAL
Intervention: Multicomponent prospective memory training
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control (no contact during training phase)
Number of subjects: 25
Study: 27575534

Group type: EXPERIMENTAL
Intervention: Social dancing classes (folk or ballroom dancing) twice weekly for 12 months (80 hours total)
Number of subjects: 530

Group type: COMPARATOR
Intervention: Control group continued with regular activities
Number of subjects: 530

Group type: EXPERIMENTAL
Intervention: Ballroom dancing
Number of subjects: 530

Group type: EXPERIMENTAL
Intervention: Folk dancing
Number of subjects: 530
Study: 24087940

Group type: EXPERIMENTAL
Intervention: IV iron sucrose therapy
Number of subjects: 11
Study: 21924507

Group type: EXPERIMENTAL
Intervention: Therapeutic sunlight exposure
Number of subjects: 30
Study: 20843575

Group type: COMPARATOR
Intervention: Peg‐interferon alpha‐2b plus 1000‐1200 mg of ribavirin daily (according to body weight) for 24 weeks (Std24)
Number of subjects: 414

Group type: EXPERIMENTAL
Intervention: Peg‐interferon alpha‐2b plus 1000‐1200 mg of ribavirin daily for variable duration of 12 or 36 weeks (Var12/36)
Number of subjects: 414

Group type: EXPERIMENTAL
Intervention: Peg‐interferon alpha‐2b plus ribavirin for 12 weeks in patients with wk4-R
Number of subjects: 414

Group type: EXPERIMENTAL
Intervention: Peg‐interferon alpha‐2b plus ribavirin for 36 weeks in patients with wk4-R
Number of subjects: 414

Group type: COMPARATOR
Intervention: Peg‐interferon alpha‐2b plus ribavirin for 24 weeks in patients without wk4-R
Number of subjects: 414

Group type: EXPERIMENTAL
Intervention: Peg‐interferon alpha‐2b plus ribavirin for variable duration in patients without wk4-R
Number of subjects: 414
Study: 18389446

Group type: EXPERIMENTAL
Intervention: Back-to-back video colonoscopy
Number of subjects: 294
Study: 16983910

Group type: EXPERIMENTAL
Intervention: Tongfu Xiere Recipe (TXR) combined with basic therapy (conventional treatment and antibiotics)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Basic therapy alone (control group)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Tongfu Xiere Recipe (TXR) combined with basic therapy
Number of subjects: 89
Study: 12713210

Group type: EXPERIMENTAL
Intervention: Child-targeted program
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Parent-targeted program
Number of subjects: 60

Group type: COMPARATOR
Intervention: Comparison intervention (global self-esteem)
Number of subjects: 60
Study: 10995404

Group type: EXPERIMENTAL
Intervention: Esmolol
Number of subjects: 20

Group type: COMPARATOR
Intervention: Nicardipine
Number of subjects: 20
Study: 8648918

Group type: EXPERIMENTAL
Intervention: OKT3
Number of subjects: 312

Group type: COMPARATOR
Intervention: CsA
Number of subjects: 312
Study: 1381102

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 36

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 6495747

Group type: EXPERIMENTAL
Intervention: Synthetic secretin (Hoechst) alone
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Synthetic secretin (Hoechst) + natural CCK
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Post-infusion of synthetic secretin + natural CCK
Number of subjects: 11
Study: 31741209

Group type: EXPERIMENTAL
Intervention: Task-oriented circuit training combined with aerobic training (TOCT-AT)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Aerobic training (AT)
Number of subjects: 26
Study: 30307640

Group type: EXPERIMENTAL
Intervention: Complete chemo‐mechanical disinfection (CMD) of the root canal system
Number of subjects: 57

Group type: COMPARATOR
Intervention: Removal of necrotic tissue from the pulp chamber (RNT)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Both groups (CMD and RNT)
Number of subjects: 57
Study: 29408901

Group type: EXPERIMENTAL
Intervention: WHELD intervention
Number of subjects: 847

Group type: COMPARATOR
Intervention: TAU (treatment as usual)
Number of subjects: 847
Study: 26706397

Group type: EXPERIMENTAL
Intervention: Model training for anterior repair (AR)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Model training for posterior repair (PR)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Model training for vaginal hysterectomy (VH)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control (no training)
Number of subjects: 19
Study: 24522223

Group type: EXPERIMENTAL
Intervention: Repeat Back (RB)
Number of subjects: 575

Group type: COMPARATOR
Intervention: Standard iMedConsent (no RB)
Number of subjects: 575
Study: 23290159

Group type: EXPERIMENTAL
Intervention: Telmisartan (40 - 80 mg qd)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Amlodipine (5 - 10 mg qd)
Number of subjects: 48
Study: 20347404

Group type: EXPERIMENTAL
Intervention: IDet before lunch
Number of subjects: 39

Group type: COMPARATOR
Intervention: IDet bedtime
Number of subjects: 39

Group type: COMPARATOR
Intervention: IDet-12h
Number of subjects: 39
Study: 19278079

Group type: EXPERIMENTAL
Intervention: Baking soda dentifrices (20% to 65% baking soda)
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Baking soda dentifrices
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Baking soda dentifrices with higher concentrations of baking soda
Number of subjects: 270

Group type: COMPARATOR
Intervention: Non-baking soda dentifrices
Number of subjects: 270
Study: 15766997

Group type: EXPERIMENTAL
Intervention: Multiple micronutrient supplement providing a recommended daily allowance of 15 vitamins and minerals
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Routine iron and folic acid supplements (control)
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Multiple micronutrient supplement
Number of subjects: 1200
Study: 12648027

Group type: EXPERIMENTAL
Intervention: Intravenous ketoprofen 1 mg/kg
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Rectal ketoprofen 25 mg (dose normalized to 1 mg/kg)
Number of subjects: 28
Study: 10716682

Group type: EXPERIMENTAL
Intervention: PMF-100 (250 ml twice daily; PEG 14.6 g twice daily)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: PMF-100
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 8613657

Group type: COMPARATOR
Intervention: 0 g lactose in water
Number of subjects: 13

Group type: COMPARATOR
Intervention: 2 g lactose in water
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 6 g lactose in water
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 12 g lactose in water
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 20 g lactose in water
Number of subjects: 13
Study: 1359818

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium (10 mg) inhaled 10 min before challenge with 4.5% NaCl
Number of subjects: 16

Group type: COMPARATOR
Intervention: Vehicle inhaled 10 min before challenge with 4.5% NaCl
Number of subjects: 16
Study: 4080922

Group type: EXPERIMENTAL
Intervention: Alcohol-drinking group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tonic-drinking group
Number of subjects: 0
Study: 30215676

Group type: EXPERIMENTAL
Intervention: Alectinib 600 mg twice daily
Number of subjects: 303

Group type: COMPARATOR
Intervention: Crizotinib 250 mg
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Alectinib
Number of subjects: 303
Study: 26787273

Group type: EXPERIMENTAL
Intervention: Fundoplication in children with neurological impairment (NI)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Fundoplication in children without neurological impairment (non-NI)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Parental satisfaction after fundoplication
Number of subjects: 87
Study: 24099659

Group type: EXPERIMENTAL
Intervention: Abiraterone acetate (1000 mg) plus low-dose prednisone (5 mg twice daily)
Number of subjects: 331

Group type: COMPARATOR
Intervention: Placebo plus low-dose prednisone (5 mg twice daily)
Number of subjects: 331
Study: 22054915

Group type: EXPERIMENTAL
Intervention: Tailored self‐help smoking cessation intervention
Number of subjects: 1284

Group type: COMPARATOR
Intervention: Standard brochure
Number of subjects: 1284
Study: 19691033

Group type: EXPERIMENTAL
Intervention: Supportive psychotherapy (6-session manualized intervention)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo (in parallel to supportive psychotherapy)
Number of subjects: 59
Study: 18517044

Group type: EXPERIMENTAL
Intervention: Actillume monitoring for one week
Number of subjects: 44
Study: 16043677

Group type: EXPERIMENTAL
Intervention: Topiramate (escalating dose from 25 to 300 mg/d)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study: 12458444

Group type: EXPERIMENTAL
Intervention: MultiHance (0.1 mmol/kg bw)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Gadovist (0.1 mmol/kg bw)
Number of subjects: 12
Study: 11888361

Group type: EXPERIMENTAL
Intervention: Stratified care strategy (initial therapy based on clinical need, included zolmitriptan)
Number of subjects: 835

Group type: COMPARATOR
Intervention: Stepped care across attacks (first-line therapy with simple combination analgesic escalated to zolmitriptan if inadequate response)
Number of subjects: 835

Group type: COMPARATOR
Intervention: Stepped care within attacks (first-line therapy with simple combination analgesic escalated to zolmitriptan if inadequate response)
Number of subjects: 835

Group type: EXPERIMENTAL
Intervention: Stratified care strategy
Number of subjects: 835
Study: 9862606

Group type: EXPERIMENTAL
Intervention: Sertraline (50-200 mg daily)
Number of subjects: 635

Group type: COMPARATOR
Intervention: Imipramine (50-300 mg daily)
Number of subjects: 635

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 635

Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 635
Study: 7621460

Group type: EXPERIMENTAL
Intervention: Combination therapy with EMP 280 mg twice a day and suramin 1 g weekly infusions for 6 weeks
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Combination therapy with EMP and suramin
Number of subjects: 32

Group type: COMPARATOR
Intervention: EMP 280 mg alone
Number of subjects: 32
Study: 2220259

Group type: EXPERIMENTAL
Intervention: Recombinant methionyl growth hormone (GH) 0.5-0.6 IU.kg-1.week-1
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 76797

Group type: EXPERIMENTAL
Intervention: alpha‐isomer of flupenthixol
Number of subjects: 45

Group type: COMPARATOR
Intervention: beta‐flupenthixol
Number of subjects: 45

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 45
Study: 6353923

Group type: EXPERIMENTAL
Intervention: Cefoxitin solution
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Cephapirin solution
Number of subjects: 128

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 128
Study: 29730000

Group type: EXPERIMENTAL
Intervention: Freitod (free death)
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: Suizid (suicide)
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: Selbstmord (self-murder)
Number of subjects: 451
Study: 26651376

Group type: EXPERIMENTAL
Intervention: Intensive Physical Therapy (PT) program, 12.4 ± 6.5 sessions for a total of 408 ± 261 minutes
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard-of-care PT program, 6.1 ± 3.8 sessions for 86 ± 63 minutes
Number of subjects: 120
Study: 24232665

Group type: EXPERIMENTAL
Intervention: Mozart music
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Bach music
Number of subjects: 12

Group type: COMPARATOR
Intervention: No music
Number of subjects: 12
Study: 23102175

Group type: EXPERIMENTAL
Intervention: Home-delivered DASH meals
Number of subjects: 298

Group type: COMPARATOR
Intervention: Control group (no meals)
Number of subjects: 298